Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implicationsCapsule Summary
Introduction: Treating chronic pruritus is challenging for dermatologists due to the lack of therapeutic options. We review the effects of κ-opioid receptor (KOR) and μ-opioid receptor (MOR) in the modulation of itch, summarize evidence supporting the efficacy and safety of opioid receptor-targeting...
Saved in:
Main Authors: | Sarina Elmariah, MD, PhD (Author), Sarah Chisolm, MD (Author), Thomas Sciascia, MD (Author), Shawn G. Kwatra, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between chronic pruritus, depression, and insomnia: A cross-sectional studyCapsule Summary
by: Jaein Lee, MD, et al.
Published: (2021) -
Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammationCapsule Summary
by: Jaya Manjunath, BS, et al.
Published: (2024) -
Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)Capsule Summary
by: Gil Yosipovitch, MD, et al.
Published: (2024) -
Predictive factors of quality of life in chronic pruritus patients: A cross-sectional studyCapsule Summary
by: Siri Choragudi, BS, et al.
Published: (2023) -
Trends in dermatology eponymsCapsule Summary
by: Lin He, MD, PhD, et al.
Published: (2022)